SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Cambridge Antibody Technology Group
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Jongmans who started this subject8/4/2003 4:31:12 PM
From: nigel bates   of 625
 
Bizarrely, this was not announced in the UK -

UPDATE - Cambridge Antibody files $175 mln equity shelf
Tuesday July 29, 4:04 pm ET
WASHINGTON, July 29 (Reuters) - Cambridge Antibody Technology Group Plc (London:CAT.L - News; NasdaqNM:CATG - News) on Tuesday filed with the U.S. Securities and Exchange Commission (News - Websites) to periodically sell up to $175 million in ordinary shares.
The Cambridge, England-based biotechnology company said it plans to use the proceeds from the shelf offering for general corporate purposes.
Its shares closed up 18 cents, or 2.5 percent, at $7.45 on Nasdaq.
Under a shelf registration, a company may sell securities in one or more separate offerings with the size, price and terms to be determined at the time of sale...
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News